Announce Date | 05/01/2025 |
EPS Normalized Actual | $0.13 (Beat by $0.27) |
EPS GAAP Actual | $0.13 (Beat by $0.27) |
Revenue Actual | $0.33418B |
Revenue Surprise | Beat by $334.18M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.04 |
EPS GAAP Estimate | $-0.04 |
Revenue Estimate | $0.583026B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | -0.014157 | -78.76 | -0.01423968 | -0.01410016 | 1 |
Dec 2026 | -0.10169 | -10.96 | -0.14 | -0.06179 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.13 | 0.29 | 0.33418B | -44.16% | -168.06M |
FQ4 2024 (Dec 2024) | -0.0365 | 0.017766 | -0.094051B | 772.1% | -645.59M |
FQ3 2024 (Sep 2024) | -0.0666 | -0.019717 | 0.558988B | 5.76% | -1.95M |
FQ2 2024 (Jun 2024) | -0.08 | -0.035411 | 0.558541B | -14.09% | -1.58M |
FQ1 2024 (Mar 2024) | -0.19 | 0.09 | 0.481752B | -13.22% | 132.65M |
FQ4 2023 (Dec 2023) | 0.0722 | 0.0722 | 0.632114B | -12.19% | 632.11M |
FQ3 2023 (Sep 2023) | -0.55 | -0.55 | 0.526786B | -14.45% | 526.79M |
FQ2 2023 (Jun 2023) | 0 | 0 | 0.637239B | -0.96% | 637.24M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.04
Consensus Revenue Estimates
0.583026B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | -0.02 | -- | -0.02 | -0.02 | 1 |
FQ2 2026 (Jun 2026) | -0.01 | -- | -0.01 | -0.01 | 1 |
FQ1 2026 (Mar 2026) | -0.07 | 285.71 | -0.07 | -0.07 | 1 |
FQ4 2025 (Oct 2025) | -0.04 | 8.75 | -0.04050525 | -0.03953547 | 2 |
FQ3 2025 (Jul 2025) | -0.04 | -66.5 | -0.04050525 | -0.03953547 | 2 |
FQ2 2025 (Jun 2025) | -0.04 | -100 | -0.04045955 | -0.0396855 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | 0.41B | -- | 0.41B | 0.41B | 1 |
FQ2 2026 (Jun 2026) | 0.41B | -- | 0.41B | 0.41B | 1 |
FQ1 2026 (Mar 2026) | 0.35B | 5.55 | 0.35B | 0.35B | 1 |
FQ4 2025 (Oct 2025) | 0.58B | 116.29 | 0.57B | 0.58B | 1 |
FQ3 2025 (Jul 2025) | 0.58B | 3.6 | 0.57B | 0.59B | 1 |
FQ2 2025 (Jun 2025) | 0.58B | 4.2 | 0.58B | 0.59B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.16 | 0.13 | 0.29 | 223.08% |
FQ4 2024 (Dec 2024) | -0.054266 | -0.0365 | 0.017766 | -48.67% |
FQ3 2024 (Sep 2024) | -0.046883 | -0.0666 | -0.019717 | 29.61% |
FQ2 2024 (Jun 2024) | -0.044589 | -0.08 | -0.035411 | 44.26% |
FQ1 2024 (Mar 2024) | -0.28 | -0.19 | 0.09 | -47.37% |
FQ4 2023 (Dec 2023) | 0.0722 | 0.0722 | 100% | |
FQ3 2023 (Sep 2023) | -0.55 | -0.55 | 100% | |
FQ2 2023 (Jun 2023) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.5B | $0.33B | $-168.06M | -50.29% |
FQ4 2024 (Dec 2024) | $0.55B | $-0.09B | $-645.59M | 686.43% |
FQ3 2024 (Sep 2024) | $0.56B | $0.56B | $-1.95M | -0.35% |
FQ2 2024 (Jun 2024) | $0.56B | $0.56B | $-1.58M | -0.28% |
FQ1 2024 (Mar 2024) | $0.35B | $0.48B | $132.65M | 27.54% |
FQ4 2023 (Dec 2023) | $0B | $0.63B | $632.11M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.53B | $526.79M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.64B | $637.24M | 100% |